SuiShot APM-7

SuiShot APM-7

P. multocida and A. pleuropneumoniae combined inactivated vaccine


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
South Korea
Brand name
SuiShot
Payment Terms
L/C,T/T
Production method
Available,OEM
Shipping / Lead Time
Negotiable / Negotiable
Keyword
animal vaccine, apm-7, suishot, swine vaccine
Category
Veterinary Medicine

ChoongAng Vaccine Laboratories Co., Ltd.(CAVAC)

Membership
VIP
Country / Year Established
South Korea South Korea / 1968
Business type
Manufacturer
Verified Certificate

16

TRADE TOWER

DUNS

Product name SuiShot APM-7 Certification -
Category Veterinary Medicine Ingredients Actinobacillus pleuropneumoniae serotype 2,Actinobacillus pleuropneumoniae serotype 2 toxoid,Actinobacillus pleuropneumoniae serotype 5,Actinobacillus pleuropneumoniae serotype 5 toxoid,Formalin,Immulant-α,Pasteurella multocida type A,Pasteurella multocida type D
Keyword animal vaccine , apm-7 , suishot , swine vaccine Unit Size -
Brand name SuiShot Unit Weigh -
origin South Korea Stock 0
Supply type Available,OEM HS code 300230

Product Information

    Toxoid vaccine with no side effects


    SuiShot® APM-7



    Indication

    An aid in the control and prevention of porcine pleuropneumonia and pasteurellosis in pigs.


    Composition and quantity (per dose)

    Pasteurella multocida type A..............................................4,000,000,000 CFU

    Pasteurella multocida type D..............................................4,000,000,000 CFU

    Actinobacillus pleuropneumoniae serotype 2.....................2,000,000,000 CFU

    Actinobacillus pleuropneumoniae serotype 5.....................2,000,000,000 CFU

    Actinobacillus pleuropneumoniae serotype 2 toxoid..........20㎍

    Actinobacillus pleuropneumoniae serotype 5 toxoid..........20㎍

    Immulant-α..........................................................................25%

    Formalin..............................................................................0.2%


    Features

    Protects all the serotype of actinobacillus pleuropneumoniae by neutralizing three

    toxins (APX Ⅰ,Ⅱ,Ⅲ) of actinobacillus pleuropneumoniae.

    The most common serotypes(type 2, 5) are included.

    Prevents swine pleuropneumonia , pasteurellosis and atrophic rhinitis at once.

    Formation of the vaccine immunity without the influence of antibiotic.

    Nano particle adjuvant stimulates both cell-mediated immunity and humoral immunity.

     

    Administration and dosage

    For piglets, administer 2.0㎖ intramuscularly twice at 5~7 weeks of age

    and 2 weeks post 1st vaccination.

     

    Packaging unit

    10 doses/bottle

    25 doses/bottle

 

 

 

Product Info Attached File

SuiShot APM-7.jpg

B2B Trade

Price (FOB) Negotiable transportation Air Transportation,Negotiation Other,Ocean Shipping
MOQ Negotiable Leadtime Negotiable
Payment Options L/C,T/T Shipping time Negotiable

ChoongAng Vaccine Laboratories Co., Ltd.(CAVAC)

Country / Year Established
South Korea South Korea / 1968
Membership
VIP
Business type
Manufacturer

16

TRADE TOWER

DUNS

President
Injoong Yoon
Address
1476-37 Yuseong-daero, Yuseong-gu, Daejeon, Korea
Product Category
Veterinary Medicine
Year Established
1968
No. of Total Employees
101-500
Company introduction

As an innovative animal vaccine company, CAVAC’s long journey with continuing efforts

 

CAVAC leads the way in animal health

CAVAC is a powerful leader in the field of animal biological products. We provide a wide range of groundbreaking pharmaceutical products that promote animal health and welfare, as well as improving the quality of life of people in Korea.

 

CAVAC’s long history and continued efforts

Since it was founded in 1968, CAVAC has grown to become renowned in Korea as a developer and manufacturer of animal vaccines. With over 80 animal vaccine products, the company is a key player in the Korean and global markets. We have achieved multiple vendor audits conducted by multinational companies and government audits. CAVAC is also committed to finding better solutions for pharmaceutical, biological and diagnostic products, and strives to be a pioneering partner offering a wide range of services.

 

Global bio leader in the advanced animal vaccine industry

As an animal vaccine company, CAVAC has experienced accelerated growth. As well as enhancing the development of new products and technologies, we have maximized our investments to protect against challenges and competition from various global companies. CAVAC is strategically located in the Daedeok Innopolis, also known as the Silicon Valley of Korea, and has teamed up with a number of prominent research institutions. CAVAC is now expanding onto the global market and is striving to become one of the top 10 global partners in animal health.

Main Markets

Bangladesh Bangladesh

Cambodia Cambodia

Indonesia Indonesia

Myanmar Myanmar

Nepal Nepal

Pakistan Pakistan

Philippines Philippines

Thailand Thailand

Viet Nam Viet Nam

Factory Information

(주)중앙백신연구소,

주식회사 중앙백신연구소

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My TK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more